Clinical Trial Update: Randomized Evaluation of the Efficacy of Synvisc-One® for the Treatment of Patellofemoral Chondromalacia [NA]

View source ↗

Summary

A completed randomized trial evaluating the efficacy of Synvisc-One for patellofemoral chondromalacia has posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chondromalacia Patella
• Patellofemoral Pain Syndrome

Drugs mentioned

• Synvisc-One (hylan G-F 20)

Snippet

Sponsor: University of Virginia | Conditions: Chondromalacia Patella, Patellofemoral Pain Syndrome | NA | Status: COMPLETED | Results posted: 2020-09-04